Orlando, FL -- (SBWIRE) -- 10/29/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Synta Pharmaceuticals Corp.(NASDAQ:SNTA), Gilead Sciences, Inc.(NASDAQ:GILD).
Synta Pharmaceuticals Corp.(NASDAQ:SNTA) shares decreased 20.31% to $5.10. SNTA‘s stock had its “positive” rating reiterated by equities researchers at Jefferies Group in a research report issued on Oct. 28.
Additionally, the company on Oct. 28 reported more data from a study of its experimental cancer drug ganetespib. The trial compares ganetespib to the chemotherapy drug docetaxel in the treatment of advanced non-small cell lung adenocarcinoma, a type of lung cancer. The study is designed to identify the patients who might benefit the most from ganetespib. The company said that patients who were treated with ganetespib and docetaxel had median survival of 10.7 months, and patients treated with docetaxel alone had median survival of 7.4 months. A final analysis of the study is expected in early 2014.
Are investors worried about the recent updates with SNTA? Find out with a free trend analysis HERE
Gilead Sciences, Inc.(NASDAQ:GILD) shares decreased 1.36% to $68.73. The Food and Drug Administration issued a positive review on Oct. 23 for a highly anticipated hepatitis C drug from Gilead Sciences (GILD), saying the pill cures more patients in less time than currently available treatments. The agency posted its review of Gilead's sofosbuvir online ahead of a meeting Friday where government experts will vote on whether to recommend the drug's approval. Between 3 million and 4 million people in the U.S. have hepatitis C, a blood-borne disease that causes liver damage and is blamed for 15,000 deaths a year.
Is GILD going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)